These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1208643)

  • 41. Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II.
    Abdel-Razik AE; Balment RJ; Ashton N
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1239-47. PubMed ID: 18701623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of central urotensin II on heart rate, blood pressure and brain Fos immunoreactivity in conscious rats.
    Watson AM; McKinley MJ; May CN
    Neuroscience; 2008 Jul; 155(1):241-9. PubMed ID: 18597948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors.
    O'Connor SW; Bale WF
    Cancer Res; 1984 Sep; 44(9):3719-23. PubMed ID: 6744289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Action mechanism and effects of ifenprodil on the regional blood flow, especially on cerebrovascular circulation].
    Hagihara Y
    Nihon Yakurigaku Zasshi; 1975 Oct; 71(7):709-25. PubMed ID: 1240069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Total and local circulation figures in rats].
    Kapitola J; Schüllerová M
    Sb Lek; 1970 Oct; 72(10):276-80. PubMed ID: 5530586
    [No Abstract]   [Full Text] [Related]  

  • 46. Regional blood flow in Dahl-Iwai salt-sensitive rats and the effects of dietary L-arginine supplementation.
    Tomohiro A; Kimura S; He H; Fujisawa Y; Nishiyama A; Kiyomoto K; Aki Y; Tamaki T; Abe Y
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1013-9. PubMed ID: 9139995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma water and 51Cr EDTA equilibration volumes of different tissues in the rat.
    Larsson M; Johnson L; Nylander G; Ohman U
    Acta Physiol Scand; 1980 Sep; 110(1):53-7. PubMed ID: 6781227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Change of inulin- and chloride- spaces during acute metabolic acidosis in the rat].
    Fujimoto M; Higaki K
    Nihon Seirigaku Zasshi; 1972; 34(1):16-27. PubMed ID: 5064130
    [No Abstract]   [Full Text] [Related]  

  • 50. Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney.
    Zhang AY; Chen YF; Zhang DX; Yi FX; Qi J; Andrade-Gordon P; de Garavilla L; Li PL; Zou AP
    Am J Physiol Renal Physiol; 2003 Oct; 285(4):F792-8. PubMed ID: 12783779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular contractile effect of urotensin II in young and aged rats: influence of aging and contribution of endothelial nitric oxide.
    Ishihata A; Sakai M; Katano Y
    Peptides; 2006 Jan; 27(1):80-6. PubMed ID: 16159683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue spaces in rat heart, liver, and skeletal muscle in vivo.
    Cieslar J; Huang MT; Dobson GP
    Am J Physiol; 1998 Nov; 275(5):R1530-6. PubMed ID: 9791070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes of organ blood flow and cardiac output after imidazole administration.
    Hably C; Györváry Z; Bartha J
    Acta Physiol Hung; 1994; 82(2):163-73. PubMed ID: 7887176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood volume and extracellular space (ECS) of the whole body and some organs of the rat.
    Biewald N; Billmeier J
    Experientia; 1978 Mar; 34(3):412-3. PubMed ID: 631287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urotensin-II As a Promising Key-Point of Cardiovascular Disturbances Sequel.
    Avagimyan A; Kajaia A; Gabunia L; Ghambashidze K; Sulashvili N; Ratiani L; Heshmat-Ghahdarijani K; Sheibani M; Aznauryan A
    Curr Probl Cardiol; 2022 Nov; 47(11):101074. PubMed ID: 34848248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urotensin I-CRF-Urocortins: a mermaid's tail.
    Pittman QJ; Hollenberg MD
    Gen Comp Endocrinol; 2009 Oct; 164(1):7-14. PubMed ID: 19409389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of urotensin II in cardiovascular and renal physiology and diseases.
    Zhu YC; Zhu YZ; Moore PK
    Br J Pharmacol; 2006 Aug; 148(7):884-901. PubMed ID: 16783414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The caudal neurosecretory system. A critical evaluation of the two-hormone hypothesis.
    Chan DK; Bern HA
    Cell Tissue Res; 1976 Nov; 174(3):339-54. PubMed ID: 187342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological effects of urotensins. I. Regional vascular effects of urotensins I and II in the rat.
    Medakovic M; Chan DK; Lederis K
    Pharmacology; 1975; 13(5):409-18. PubMed ID: 1208643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological effects of urotensins. II. Renal effects of urotensin I in the rat.
    Medakovic M; Chan DK; Lederis K
    Pharmacology; 1975; 13(5):419-26. PubMed ID: 1208644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.